🇺🇸 FDA
Patent

US 12377151

Immobilized endoglycosidase fusion protein and use thereof

granted A61KA61K2039/505A61K47/22

Quick answer

US patent 12377151 (Immobilized endoglycosidase fusion protein and use thereof) held by GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K47/22, A61K47/26, A61K47/545